Comment on “Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics”

Detalles Bibliográficos
Autores principales: Behdarvand Dehkordi, Fereshteh, Chehelgerdi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598925/
https://www.ncbi.nlm.nih.gov/pubmed/37880604
http://dx.doi.org/10.1186/s12014-023-09433-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598925/
https://www.ncbi.nlm.nih.gov/pubmed/37880604
http://dx.doi.org/10.1186/s12014-023-09433-w

Ejemplares similares